Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma

Current Medical Research and Opinion

Volumn 24, Issue 6, 2008, Pages 1755-1761

  Holló, Gábor ^a,b   Kóthy, Péter ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE   (Hungary)

Author keywords

Brinzolamide; Combined medication; Glaucoma; Intraocular pressure; Timolol; Travoprost

Indexed keywords

BRINZOLAMIDE; TIMOLOL PLUS TRAVOPROST; TRAVOPROST;

ADD ON THERAPY; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; EVENING DOSAGE; EYELID PRURITUS; FEMALE; HUMAN; HYPEREMIA; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; MONOTHERAPY; OCULAR HYPEREMIA; OPEN ANGLE GLAUCOMA; VISUAL ACUITY; VISUAL FIELD;

AGED; CLOPROSTENOL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; SULFONAMIDES; THIAZINES; TIMOLOL;

EID: 46449125566     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802159273     Document Type: Article

References (20)

1. Parrish, RK, Palmberg P, Sheu WP, XLT Study Group. A comparison of latanoprost, bimatoprost and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003;135:688-703
2. Netland PA, Landry T, Sullivan EK, et al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001;132:472-84
3. Barnebey HS, Orengo-Nania S, Flowers BE, et al. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed-combination ophthalmic solution. Am J Ophthalmol 2005;140:1-7
4. Claxton AJ, Cramer J, Pierce C. A systemic review of the association between dose regimens and medication compliance. Clin Ther 2001;23:1296-310
5. Robin A, Novack GD, Covert DV, et al. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol 2007;144:533-40
6. Hoy SM, Keam SJ, Keating GM. Travoprost/timolol. Drugs Ageing 2006;23:587-97
7. Kahook MY, Awadallah N, Noecker RJ. Fixed combination travoprost 0.004%/timolol 0.5% for open-angle glaucoma or ocular hypertension. Expert Rev Ophthalmol 2006;1:25-30
8. Topuzis F, Melamed S, Danesh-Meyer H, et al. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. Eur J Ophthalmol 2007;17:183-90
9. Schuman JS, Katz GJ, Lewis RA, et al. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2005;140:242-50
10. Hughes BA, Bacharach J, Craven R, et al. A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertension. J Glaucoma 2005;14:392-9
11. Holló G, Chiselita D, Petkova N, et al. The efficacy and safety of timolol maleate versus brinzolamide each given twice daily added to travoprost in patients with ocular hypertension or primary open angle glaucoma. Eur J Ophthalmol 2006;16:816-23
12. Feldman RM, Tanna AP, Gross RL, et al. Comparison of ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%. Ophthalmology 2007;114:1248-54
13. Franks W, the Brinzolamide Study Group. Ocular hypertensive efficacy and safety of brinzolamide ophthalmic suspension 1 % added to travoprost ophthalmic solution 0.004% therapy in patients with open-angle glaucoma or ocular hypertension. Curr Med Res Opin 2006;22:1643-9
14. European Glaucoma Society. Terminology and Guidelines for Glaucoma, 2nd edn. Savona: Dogma S.r.l., 2003
15. Denis P, Andrew R, Wells D, et al. A comparison of morning and evening instillation of a combination of travoprost 0.004%/timolol 0.5% ophthalmic solution. Eur J Ophthalmol 2006;16:407-15
16. Konstas AGP, Tsironi S, Vakalis AN, et al. 24-hour intraocular pressure control with evening versus morning dosed travoprost/timolol fixed combination in primary open-angle and exfoliative glaucoma. Acta Ophthalmol Scand 2008 (In press)
17. Holló G. Use of topical carbonic anhydrase inhibition in glaucoma treatment. In: Orgül S, Flammer J, editors. Pharmacotherapy in Glaucoma. Bern: Hans Huber Verlag; 2000. p. 145-52
18. Silver LH, the Brinzolamide Primary Therapy Study Group. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Am J Ophthalmol 1998;126:400-8
19. Michaud JE, Friren B. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001;132:235-43
20. Silver LH, Brinzolamide Confort Study Group. Ocular comfort of brinzolamide 1% ophthalmic suspension compared with dorzolamide 2% ophthalmic solution: results from two multicenter comfort studies. Surv Ophthalmol 2000;44(S2):S141-5